Ingabe Imikhiqizo ye-OTC entsha ye-Asthma ivikelekile?
Ukuphathwa Kwezokudla Nezidakamizwa (FDA) kusanda kuphakamisa ukukhathazeka kwezokuphepha kwe-Asthmanefrin ngenxa yomkhiqizo we-counter okusetshenziselwa ukuphumula okwesikhashana izimpawu zesifo se-asthma. Encwadini ethunyelwe enkampanini, i-FDA ithi inkampani kumele iphendule ngokukhathazeka futhi inikeze uhlelo lokuthi lihlela kanjani ukubhekana nokukhathazeka.
Lokhu kubangela ukungezwani kwangempela kodokotela, iziguli, kanye ne-FDA.
Iziguli eziningi azikho umshuwalense wezempilo ozivumela ukuba zifinyelele njalo ekunakekelweni kwezokwelapha futhi zibheke ezidakamizwa ze-OTC ukuze zihlangabezane nezidingo zezempilo eziningi. Njengoba kunikezwe ukuthi i-asthma ejwayelekile kangakanani, ingxenye enkulu ye-uninsured noma ngaphansi kweziguli eziphephile izoba ne-asthma. I-FDA inomsebenzi wokuqinisekisa ukuthi izidakamizwa zihlolwe ngokufanele ukuphepha nokusebenza. Odokotela bavame ukubekwa phakathi nendawo ukubhekana nokunakekelwa kwabantu ngabanye.
Ngaphandle kokukhathazeka kokuphepha kukhona nokukhathazeka ngokuthi ngabe imikhiqizo ye-OTC iyasebenza yini njengoba izinketho zemithi kadokotela.
Yini Okukhathazayo Ukuphepha Kwe-Asthmanefrin?
I-Asthmanefrin yakhululwa ngo-Septhemba 2012 ngemuva kwesikhathi lapho kwakungekho khona ngaphezu kwemikhiqizo ye-asthma ngenxa yokukhathazeka kwemvelo ngenxa ye- CFCs kuma-inhalers asebekhulile. Esitatimendeni sabo, i-FDA ikhulume ngezenzakalo eziningi ezimbi kusukela kukhishwe i-Asthmanefrin kufaka:
- isihlunu (ukuzwa ugula esiswini sakho)
- ukuhlanza
- umfutho wegazi ophakeme
- ukwanda kwentando yenhliziyo
- i-hemoptysis (ukukhwehlela igazi kukhishwa i-sputum enombala obomvu)
Ukwengeza, sekuvele nje ukukhumbula ngenxa yengozi yokuchofoza ehambisana ne-EZ Breathe Atomizers. Kukhona ukukhathazeka ukuthi i-washer ingakwazi ukukhishwa ngesikhathi sokusetshenziswa.
Ukukhathazeka kokuphepha akuyona into entsha ngaphezu kwemikhiqizo ye-counter-asthma. Abahlengikazi nezinkampani ezikhathazekile baye babonisa ukuthi imishanguzo ye-counter-the-counter ayithengiswa nge-hypertension, isifo senhliziyo noma izinkinga ze-cholesterol ngakho-ke kungani kufanele zibe khona nge-asthma?
Ucwaningo olwedlule luye lwabonisa ukuthi imikhiqizo ye-asthma ye-OTC iphephile, kodwa okungenani oyedwa kwabayisihlanu abasebenzisa izidakamizwa ze-otc akufanele kube. Ukwengeza, imikhiqizo efana ne-Asthmanefrin iye yahlotshaniswa nokusetshenziswa kwezinsizakalo zodokotela kanye nezidakamizwa ezifana ne-steroid engatholakali engakwazi ukulawula ukulawula isifo se-asthma . Ngokuvamile, uma udinga noma yiluphi uhlobo lwe-counter prodict ukuze uthole usizo lwe-asthma njengezimpawu kunokuba udinga ukubona udokotela noma uchwepheshe wezezempilo ukuze ahlole lezo zimpawu.
Iyini i-Asthmanefrin Futhi i-EZ Breathe Atomizer?
I-Asthmanefrine i-racepinephrine yamanzi noma i-racemic epinephrine, lapho isetshenziselwa i-EZ Breathe Atomizer, ishintshwa ibe yiphunga eliqhubekayo elinyanyiselwa emaphashini.
I-FDA Incwadi Eyisixwayiso kuNefron Pharmaceuticals Corporation
Incwadi yokuxwayisa kwabenzi be-Asthmanefrin igxile ezindaweni eziningana. Okokuqala, incwadi yokuxwayisa ithi i-Asthmanefrin impela "isidakamizwa esisha" esingavunyelwe esingahlolwa yi-FDA ngokuphepha nokusebenza ngaphansi kwenqubo entsha yokufaka izicelo zezidakamizwa.
I-FDA ithi futhi le nkampani ithengisa i-atomizer yayo yokusebenzisa "ehlukile ekusetshenzisweni komshini odayiswe ngokomthetho ngohlobo olujwayelekile lwedivaysi. "I-FDA iphinde ithi inkampani yokwelapha yenza amacala angalungile ekukhangiseni kwabo njengokuthi isimangalo sokuthi i-Asthmanefrin" yindlela eya ku-Primatene Mist CFC Inhaler. "I-FDA ithi inkampani ayikho idatha yokusekela ukuthi izidakamizwa ezimbili zifaniswa. Ukwengeza, i-FDA ikhathazekile ngokuthi ukudukisa kungaholela ekusetshenzisweni okungalungile iziguli ezine-asthma.
I-FDA ibuye iveze ezinye zezimpikiswano zabo zokuphepha ezifaka ukuhlaselwa kwesifuba esibulalayo ekubhaleleni inkampani.
Izinkinga zokukhathazeka ngenani lomkhiqizo osebenzayo zinganakekelwa ngokuthembekile ezigulini ezisebenzisa i-inhaler kanye nemiphumela ebonakalayo engase iholele kuyo. Ngokufanayo, uma isiguli sithola imithi eningi kakhulu kunokukhathazeka mayelana nemiphumela emibi yezinhliziyo. >
Kumele ngenzeni
Uma udinga ukusebenzisa ngaphezulu komkhiqizo we-counter like Asthmanefrin kufanele ubone udokotela mayelana nezimpawu zakho. I-asthma yisimo lapho ungase uhambe khona ngokushesha. Ngikhathazekile ngokuthi isiguli esisebenzisa umkhiqizo we-otc asthma siyogwema ihhovisi legqirha futhi sithuthukise izimpawu ezingathí sina.
Uma udinga ukusebenzisa njalo i-inhaler futhi usebenzisa imikhiqizo ye-OTC ngenxa yokukhathazeka kwezezimali, uhlelo losizo lwesiguli oluxhaswe yizinkampani eziningi ezidakamizwa lungakusiza ukuthola imithi yakho ye-asthma mahhala noma ngezindleko ezincishisiwe kakhulu. Imfanelo ngokuvamile isekelwe kwisidingo sokugcina esishiya ezinye zeziguli zami ezizizwa zidinga njengokuthi zisuke zikhulile uma zingabhekeleki. Izinhlelo zingaba nzima ukuphatha nokuzulazula ukuze ufune ukucela isisebenzi senhlalakahle noma umphathi wezinso usizo.
Imithombo
I-FDA Isexwayiso ku-Nephron Pharmaceuticals Corp. 9/24/13. Kufinyelelwe ngo-Ephreli 16, 2016.
Kuschner WG, Hankinson TC, Wong HC kanye ne-Blanc PD. Ukusetshenziswa kwemithi ye-Bronchodilator engabhalwanga ku-Asthma. I-Chest 1997; 112; 987-993.
I-Dickinson BD, i-Altman RD, i-Deitchman SD ne-Champion HC. Ukuphepha kwe-Over-the-Counter Inhalers ye-Asthma. I-Chest 2000; 118; 522-526.